Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, NCHS Data Brief, issue.177, pp.1-8, 2003. ,
A systematic review of statin-induced muscle problems in clinical trials, American Heart Journal, vol.168, issue.1, pp.6-15 ,
DOI : 10.1016/j.ahj.2014.03.019
Statin Safety: A Systematic Review, The American Journal of Cardiology, vol.97, issue.8, pp.52-60, 2006. ,
DOI : 10.1016/j.amjcard.2005.12.010
Guidance to manage inappropriate polypharmacy in older people: systematic review and future developments, Expert Opinion on Drug Safety, vol.16, issue.2, pp.203-216, 2017. ,
DOI : 10.1080/14740338.2017.1265503
URL : https://openair.rgu.ac.uk/bitstream/10059/2071/3/STEWART%202016%20Guidance%20to%20manage%20inappropriate%20polypharmacy.pdf
Prevalence of statin-drug interactions in older people: a systematic review, European Journal of Clinical Pharmacology, vol.32, issue.3, pp.513-534, 2016. ,
DOI : 10.1007/s40266-015-0302-9
Age-Related Differences in the Prevalence of Potential Drug-Drug Interactions in Ambulatory Dyslipidaemic Patients Treated with Statins, Drugs & Aging, vol.26, issue.1, pp.429-469, 2007. ,
DOI : 10.2165/00002512-200724050-00006
Agence nationale de sécurité du médicament et des produits de santé [Internet] Available from: http://ansm.sante.fr/Dossiers/Interactions-medicamenteuses/Interactionsmedicamenteuses ,
Available from: http://www.vidalfrance.com/solutions/solutions-professionnels/vidal-hoptimal/ 10, Thériaque [Internet]. [cited 2017 May 17]. Available from ,
Drug interaction databases in medical literature: transparency of ownership, funding, classification algorithms, level of documentation, and staff qualifications. A systematic review, European Journal of Clinical Pharmacology, vol.13, issue.11, pp.1397-402, 2015. ,
DOI : 10.1186/2050-6511-13-7
Semantic integration of medication data into the EHOP Clinical Data Warehouse, Stud Health Technol Inform, vol.210, pp.702-708, 2015. ,
Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin, Expert Opinion on Drug Metabolism & Toxicology, vol.5, issue.1, pp.51-65, 2014. ,
DOI : 10.2217/pgs.09.18
Drug???drug interactions that interfere with statin metabolism, Expert Opinion on Drug Metabolism & Toxicology, vol.60, issue.6, pp.1435-1482, 2015. ,
DOI : 10.1093/ajh/6.11.375S
Statin drug interactions and related adverse reactions, Expert Opinion on Drug Safety, vol.42, issue.1, pp.933-979 ,
DOI : 10.1016/j.ejps.2011.09.009
Available from: https ,
Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites, The Journal of Clinical Pharmacology, vol.65, issue.5, pp.23-39 ,
DOI : 10.1097/QAI.0000000000000090
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association, Circulation, vol.134, issue.21, pp.468-95, 2016. ,
DOI : 10.1161/CIR.0000000000000456
Clinically Significant Drug Interactions with Cyclosporin, Clinical Pharmacokinetics, vol.30, issue.2, pp.141-79, 1996. ,
DOI : 10.2165/00003088-199630020-00004
Impact of OATP transporters on pharmacokinetics, British Journal of Pharmacology, vol.62, issue.2, pp.693-705, 2009. ,
DOI : 10.1111/j.1365-2125.2006.02686.x
Evaluation of the Performance of Drug-Drug Interaction Screening Software in Community and Hospital Pharmacies, Journal of Managed Care Pharmacy, vol.12, issue.5, pp.383-392, 2006. ,
DOI : 10.18553/jmcp.2006.12.5.383
Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care, Journal of Clinical Pharmacy and Therapeutics, vol.27, issue.1, pp.63-70, 2015. ,
DOI : 10.1046/j.1365-2710.2002.00434.x
Potential drug???drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors, International Journal of Clinical Pharmacy, vol.71, issue.suppl, pp.1021-1028, 2015. ,
DOI : 10.1007/s00280-013-2162-5
Concordance of Severity Ratings Provided in Four Drug Interaction Compendia, Journal of the American Pharmacists Association, vol.44, issue.2, pp.136-177, 2003. ,
DOI : 10.1331/154434504773062582
Black Box Warning Contraindicated Comedications: Concordance Among Three Major Drug Interaction Screening Programs, Annals of Pharmacotherapy, vol.61, issue.1, pp.28-34, 2010. ,
DOI : 10.1016/j.jaci.2005.10.031
Evaluation of frequently used drug interaction screening programs, Pharmacy World & Science, vol.44, issue.2, pp.367-74, 2008. ,
DOI : 10.1016/S1086-5802(16)31244-X
Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision support. Drug Saf, Feb, vol.38, issue.2, pp.197-206, 2015. ,
High-priority drugdrug interactions for use in electronic health records, J Am Med Inform Assoc, 2012. ,
Comparative assessment of four drug interaction compendia, British Journal of Clinical Pharmacology, vol.41, issue.6, pp.709-723, 2007. ,
DOI : 10.1331/154434504773062573
Guidance for industry: drug interaction studies?study design, data analysis, and implications for dosing and labeling recommendations: draft guidance. 2012. US Department of Health and Human Services Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/uc m292362.pdf. 35. Guideline on the investigation of drug interaction shttp, 2014. ,
Predicting the Clinical Relevance of Drug Interactions From Pre-Approval Studies, Drug Safety, vol.315, issue.6, pp.1017-1056, 2009. ,
DOI : 10.1136/bmj.315.7115.1096
Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother, pp.674-80, 2007. ,
Clinical Relevance of Drug-Drug Interactions, Drug Safety, vol.53, issue.12, pp.1131-1140, 2005. ,
DOI : 10.2165/00002018-200528120-00007
Prevalence of drug???drug interactions at hospital entry and during hospital stay of patients in internal medicine, European Journal of Internal Medicine, vol.19, issue.6, pp.413-415, 2008. ,
DOI : 10.1016/j.ejim.2007.12.002